Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT00662103
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of breast cancer
* Stage 0-III disease
* Completed chemotherapy or radiotherapy \> 2 years ago
* Is not a regular participant in moderate aerobic exercise (i.e., jogging, swimming) or moderate resistance exercise (\> 3 times/week for ≥ 30 minutes/session) OR in vigorous aerobic or resistance exercise (\> 3 times/week for ≥ 20 minutes/session)
* No stage IV breast cancer
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Menopausal status not specified
* Has obtained medical clearance to participate in study exercise programs
* No cognitive difficulties that would preclude answering the survey questions, participating in the performance tests, or giving informed consent
* No medical condition or movement or neurological disorder that would contraindicate participation in moderate intensity exercise training, as determined by physician clearance and the Principal Investigator
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No concurrent medication that would contraindicate participation in moderate intensity exercise training, as determined by physician clearance and the Principal Investigator
* Concurrent hormonal therapy (e.g., selective estrogen receptor modulator (SERM) or aromatase inhibitor) for breast cancer allowed
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
65 Years
Maximum Age:
120 Years
Study:
NCT00662103
Study Brief:
Protocol Section:
NCT00662103